Assessment of Neutrophil-to-Lymphocyte Ratio as A Prognostic Marker in Locally Advanced Head and Neck Cancer Treated with Concomitant Chemoradiation

Catégorie d'article: Research Article

Publié en ligne: 27 oct. 2023

Pages: 15 - 22

Reçu: 22 mars 2023

Accepté: 19 juil. 2023

DOI: https://doi.org/10.2478/fco-2023-0004

Mots clés

Chemoradiation, cisplatin, head and neck cancer, neutrophil-to-lymphocyte ratio, prognosis

© 2023 Elisha Servorip Targain et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.